{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:51:36Z","timestamp":1791460296665,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03418-z","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:02:36Z","timestamp":1791453756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered mesenchymal stem cell-derived small extracellular vesicles delivering miR-124 suppress colorectal cancer progression through EZH2 downregulation and attenuation of STAT3 signaling"],"prefix":"10.1007","volume":"43","author":[{"given":"Roudabeh","family":"Behzadi Andouhjerdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakineh","family":"Zivari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokoufeh","family":"Salkhordeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmida","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima Sadat","family":"Naji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Pourtahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Khanabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Golbahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Hajesmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Asbaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Norouz-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Akbarabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Ghazimoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Babashah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Piravar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"5","key":"3418_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16051029","volume":"16","author":"WH Gmeiner","year":"2024","unstructured":"Gmeiner WH. Recent advances in therapeutic strategies to improve colorectal cancer treatment. Cancers (Basel). 2024;16(5):1029.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"3418_CR2","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial\u2013mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22(8):e358\u201368.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3418_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13670-z","volume":"7","author":"L Vilorio-Marqu\u00e9s","year":"2017","unstructured":"Vilorio-Marqu\u00e9s L, Mart\u00edn V, Diez-Tasc\u00f3n C, Gonz\u00e1lez-Sevilla MF, Fern\u00e1ndez-Villa T, Honrado E, et al. The role of EZH2 in overall survival of colorectal cancer: a meta-analysis. Sci Rep. 2017;7(1):13806.","journal-title":"Sci Rep"},{"key":"3418_CR4","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20240607","author":"H Deng","year":"2025","unstructured":"Deng H, Xu Q, Zhang Q, Liu C, Ren L. EZH2 promotes chemoresistance in colorectal cancer by inhibiting autophagy through NRP1 suppression. Biochem J. 2025. https:\/\/doi.org\/10.1042\/BCJ20240607.","journal-title":"Biochem J"},{"issue":"19","key":"3418_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914815","volume":"24","author":"J Lu","year":"2023","unstructured":"Lu J, Kornmann M, Traub B. Role of epithelial to mesenchymal transition in colorectal cancer. Int J Mol Sci. 2023;24(19):14815.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3418_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo Y-Q, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther. 2024;9(1):266.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3418_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/ijmm.2021.4847","volume":"47","author":"R Ahmad","year":"2021","unstructured":"Ahmad R, Singh JK, Wunnava A, Al-Obeed O, Abdulla M, Srivastava SK. Emerging trends in colorectal cancer: Dysregulated signaling pathways. Int J mol med. 2021;47(3):14.","journal-title":"Int J mol med."},{"key":"3418_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6261721","author":"P Parcesepe","year":"2016","unstructured":"Parcesepe P, Giordano G, Laudanna C, Febbraro A, Pancione M. Cancer\u2010associated immune resistance and evasion of immune surveillance in colorectal cancer. Gastroenterol Res Pract. 2016. https:\/\/doi.org\/10.1155\/2016\/6261721.","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"3418_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081172","volume":"11","author":"L Pedrosa","year":"2019","unstructured":"Pedrosa L, Esposito F, Thomson TM, Maurel J. The tumor microenvironment in colorectal cancer therapy. Cancers. 2019;11(8):1172.","journal-title":"Cancers"},{"key":"3418_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016646","volume":"13","author":"J Shan","year":"2022","unstructured":"Shan J, Han D, Shen C, Lei Q, Zhang Y. Mechanism and strategies of immunotherapy resistance in colorectal cancer. Front Immunol. 2022;13:1016646.","journal-title":"Front Immunol"},{"key":"3418_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.869010","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, Chen D, Shen M. Tumor microenvironment shapes colorectal cancer progression, metastasis, and treatment responses. Front Med. 2022;9:869010.","journal-title":"Front Med"},{"issue":"14","key":"3418_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.7150\/ijbs.25720","volume":"14","author":"S Guo","year":"2018","unstructured":"Guo S, Deng C-X. Effect of stromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci. 2018;14(14):2083.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"3418_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836\u201348.","journal-title":"Cancer Cell"},{"issue":"1","key":"3418_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0975-5","volume":"18","author":"I Li","year":"2019","unstructured":"Li I, Nabet BY. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol Cancer. 2019;18(1):32.","journal-title":"Mol Cancer"},{"issue":"1","key":"3418_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01650-5","volume":"21","author":"Z Lin","year":"2022","unstructured":"Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022;21(1):179.","journal-title":"Mol Cancer"},{"issue":"4","key":"3418_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02675-8","volume":"42","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Hassani M, Moghaddam MB, Fazilat A, Ojarudi M, Valilo M. Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance. Med Oncol. 2025;42(4):108.","journal-title":"Med Oncol"},{"issue":"9","key":"3418_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092350","volume":"12","author":"R Cohen","year":"2020","unstructured":"Cohen R, Pudlarz T, Delattre J-F, Colle R, Andr\u00e9 T. Molecular targets for the treatment of metastatic colorectal cancer. Cancers (Basel). 2020;12(9):2350.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"3418_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.trecan.2016.08.001","volume":"2","author":"DV Tauriello","year":"2016","unstructured":"Tauriello DV, Batlle E. Targeting the microenvironment in advanced colorectal cancer. Trends Cancer. 2016;2(9):495\u2013504.","journal-title":"Trends Cancer"},{"issue":"8","key":"3418_CR19","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ejca.2011.02.008","volume":"47","author":"S Babashah","year":"2011","unstructured":"Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer. 2011;47(8):1127\u201337.","journal-title":"Eur J Cancer"},{"issue":"12","key":"3418_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0295-y","volume":"31","author":"MA Javidi","year":"2014","unstructured":"Javidi MA, Ahmadi AH, Bakhshinejad B, Nouraee N, Babashah S, Sadeghizadeh M. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31(12):295.","journal-title":"Med Oncol"},{"issue":"2","key":"3418_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020136","volume":"14","author":"E Jung","year":"2021","unstructured":"Jung E, Choi J, Kim J-S, Han T-S. MicroRNA-based therapeutics for drug-resistant colorectal cancer. Pharmaceuticals (Basel). 2021;14(2):136.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"3418_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092791","volume":"19","author":"L Ding","year":"2018","unstructured":"Ding L, Lan Z, Xiong X, Ao H, Feng Y, Gu H, et al. The dual role of microRNAs in colorectal cancer progression. Int J Mol Sci. 2018;19(9):2791.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3418_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18197","volume":"28","author":"A Khalafizadeh","year":"2024","unstructured":"Khalafizadeh A, Hashemizadegan SD, Shokri F, Bakhshinejad B, Jabbari K, Motavaf M, et al. Competitive endogenous RNA networks: decoding the role of long non\u2010coding RNAs and circular RNAs in colorectal cancer chemoresistance. J Cell Mol Med. 2024;28(7):e18197.","journal-title":"J Cell Mol Med"},{"key":"3418_CR24","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1007\/s11033-021-06347-4","volume":"48","author":"Q Li","year":"2021","unstructured":"Li Q, Liu S, Yan J, Sun M-Z, Greenaway FT. The potential role of miR-124-3p in tumorigenesis and other related diseases. Mol Biol Rep. 2021;48:3579\u201391.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3418_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/jcrt.JCRT_1090_19","volume":"17","author":"N Gautam","year":"2021","unstructured":"Gautam N, Kaur M, Kaur S. Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review. J cancer res therapeutics. 2021;17(2):311\u201326.","journal-title":"J cancer res therapeutics."},{"issue":"2","key":"3418_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.70070","volume":"5","author":"X Zhong","year":"2026","unstructured":"Zhong X, Li J, Pan M, Ke X, Cui H. Targeting EZH2 in cancer: from molecular mechanisms to clinical translation. MedComm-Oncol. 2026;5(2):e70070.","journal-title":"MedComm-Oncol"},{"issue":"1","key":"3418_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03325-7","volume":"20","author":"A Amiri","year":"2022","unstructured":"Amiri A, Bagherifar R, Ansari Dezfouli E, Kiaie SH, Jafari R, Ramezani R. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med. 2022;20(1):125.","journal-title":"J Transl Med"},{"key":"3418_CR28","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.vesic.2023.100032","volume":"3","author":"V Sharma","year":"2024","unstructured":"Sharma V, Mukhopadhyay CD. Exosome as drug delivery system: current advancements. Extracellular Vesicle. 2024;3:100032.","journal-title":"Extracellular Vesicle."},{"issue":"20","key":"3418_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205212","volume":"13","author":"T Luo","year":"2021","unstructured":"Luo T, von der Ohe J, Hass R. MSC-derived extracellular vesicles in tumors and therapy. Cancers (Basel). 2021;13(20):5212.","journal-title":"Cancers (Basel)"},{"key":"3418_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","volume":"40","author":"K Pakravan","year":"2017","unstructured":"Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1\u03b1\/VEGF signaling axis in breast cancer cells. Cell Oncol (Dordr). 2017;40:457\u201370.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"3418_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01973-w","volume":"10","author":"J Tang","year":"2024","unstructured":"Tang J, Wang X, Lin X, Wu C. Mesenchymal stem cell-derived extracellular vesicles: a regulator and carrier for targeting bone-related diseases. Cell Death Discov. 2024;10(1):212.","journal-title":"Cell Death Discov"},{"issue":"8","key":"3418_CR32","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","volume":"33","author":"SH Huang","year":"2015","unstructured":"Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, et al. Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus\u2013related oropharyngeal carcinomas. J Clin Oncol. 2015;33(8):836\u201345.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3418_CR33","doi-asserted-by":"publisher","first-page":"2B. 3.1","DOI":"10.1002\/9780470151808.sc02b03s7","volume":"7","author":"F Anjos\u2010Afonso","year":"2008","unstructured":"Anjos\u2010Afonso F, Bonnet D. Isolation, culture, and differentiation potential of mouse marrow stromal cells. Curr Protoc Stem Cell Biol. 2008;7(1):2B. 3.1-2B. 3.11.","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"3418_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","volume-title":"Histopathology: methods and protocols","author":"AT Feldman","year":"2014","unstructured":"Feldman AT, Wolfe D. Tissue processing and hematoxylin and eosin staining. In: Histopathology: methods and protocols. 2014. p. 31\u201343."},{"issue":"2","key":"3418_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23063","volume":"34","author":"A Bitaraf","year":"2020","unstructured":"Bitaraf A, Babashah S, Garshasbi M. Aberrant expression of a five\u2010microRNA signature in breast carcinoma as a promising biomarker for diagnosis. J Clin Lab Anal. 2020;34(2):e23063.","journal-title":"J Clin Lab Anal"},{"issue":"17","key":"3418_CR36","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.7150\/jca.50675","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Hu Z, Li J, Hu T. EZH2 exacerbates breast cancer by methylating and activating STAT3 directly. J Cancer. 2021;12(17):5220.","journal-title":"J Cancer"},{"issue":"4","key":"3418_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"key":"3418_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/686879","author":"M Pancione","year":"2014","unstructured":"Pancione M, Giordano G, Remo A, Febbraro A, Sabatino L, Manfrin E, et al. Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. J Immunol Res. 2014. https:\/\/doi.org\/10.1155\/2014\/686879.","journal-title":"J Immunol Res"},{"issue":"1","key":"3418_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang C-H, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"3418_CR40","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/scd.2016.0349","volume":"26","author":"GD Kusuma","year":"2017","unstructured":"Kusuma GD, Carthew J, Lim R, Frith JE. Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunities to engineer the therapeutic effect. Stem Cells Dev. 2017;26(9):617\u201331.","journal-title":"Stem Cells Dev"},{"issue":"7","key":"3418_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022;13(7):580.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3418_CR42","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s12094-023-03115-7","volume":"25","author":"J Gemayel","year":"2023","unstructured":"Gemayel J, Chaker D, El Hachem G, Mhanna M, Salemeh R, Hanna C, et al. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications. Clin Transl Oncol. 2023;25(7):2056\u201368.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"3418_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071601","volume":"9","author":"B Mir","year":"2020","unstructured":"Mir B, Goettsch C. Extracellular vesicles as delivery vehicles of specific cellular cargo. Cells. 2020;9(7):1601.","journal-title":"Cells"},{"key":"3418_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111263","volume":"121","author":"D Parashar","year":"2024","unstructured":"Parashar D, Mukherjee T, Gupta S, Kumar U, Das K. MicroRNAs in extracellular vesicles: a potential role in cancer progression. Cell Signal. 2024;121:111263.","journal-title":"Cell Signal"},{"issue":"5","key":"3418_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","volume":"40","author":"K Pakravan","year":"2017","unstructured":"Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1\u03b1\/VEGF signaling axis in breast cancer cells. Cell Oncol. 2017;40(5):457\u201370.","journal-title":"Cell Oncol"},{"key":"3418_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00384-012-1550-3","volume":"28","author":"M-J Wang","year":"2013","unstructured":"Wang M-J, Li Y, Wang R, Wang C, Yu Y-Y, Yang L, et al. Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis. 2013;28:183\u20139.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"3418_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-018-0122-2","volume":"6","author":"L Gan","year":"2018","unstructured":"Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018;6(1):10.","journal-title":"Biomark Res"},{"issue":"19","key":"3418_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193111","volume":"17","author":"S Verma","year":"2025","unstructured":"Verma S, Goyal N, Goyal S, Kaur P, Gupta S. EZH2 dysregulation and its oncogenic role in human cancers. Cancers. 2025;17(19):3111.","journal-title":"Cancers"},{"key":"3418_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ceb.2015.10.003","volume":"37","author":"E Conway","year":"2015","unstructured":"Conway E, Healy E, Bracken AP. PRC2 mediated H3K27 methylations in cellular identity and cancer. Curr Opin Cell Biol. 2015;37:42\u20138.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"3418_CR50","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/cas.14840","volume":"112","author":"J Huang","year":"2021","unstructured":"Huang J, Gou H, Yao J, Yi K, Jin Z, Matsuoka M, et al. The noncanonical role of EZH2 in cancer. Cancer Sci. 2021;112(4):1376\u201382.","journal-title":"Cancer Sci"},{"issue":"1","key":"3418_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1440-1746.2010.06447.x","volume":"26","author":"DP Tsang","year":"2011","unstructured":"Tsang DP, Cheng AS. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol. 2011;26(1):19\u201327.","journal-title":"J Gastroenterol Hepatol"},{"issue":"24","key":"3418_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29245817","volume":"29","author":"MS Gilardini Montani","year":"2024","unstructured":"Gilardini Montani MS, Benedetti R, Cirone M. Targeting EZH2 in cancer: mechanisms, pathways, and therapeutic potential. Molecules. 2024;29(24):5817.","journal-title":"Molecules"},{"issue":"10","key":"3418_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102236","volume":"14","author":"R Du","year":"2022","unstructured":"Du R, Wang C, Zhu L, Yang Y. Extracellular vesicles as delivery vehicles for therapeutic nucleic acids in cancer gene therapy: progress and challenges. Pharmaceutics. 2022;14(10):2236.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3418_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060843","volume":"13","author":"N Attia","year":"2021","unstructured":"Attia N, Mashal M, Puras G, Pedraz JL. Mesenchymal stem cells as a gene delivery tool: promise, problems, and prospects. Pharmaceutics. 2021;13(6):843.","journal-title":"Pharmaceutics"},{"key":"3418_CR55","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.reth.2025.03.006","volume":"29","author":"A Goyal","year":"2025","unstructured":"Goyal A, Afzal M, Goyal K, Ganesan S, Kumari M, Sunitha S, et al. MSC-derived extracellular vesicles: precision miRNA delivery for overcoming cancer therapy resistance. Regen Ther. 2025;29:303.","journal-title":"Regen Ther"},{"key":"3418_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.956563","volume":"10","author":"A Dalmizrak","year":"2022","unstructured":"Dalmizrak A, Dalmizrak O. Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer. Front Bioeng Biotechnol. 2022;10:956563.","journal-title":"Front Bioeng Biotechnol"},{"key":"3418_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0561-z","volume":"15","author":"Y-M Pan","year":"2016","unstructured":"Pan Y-M, Wang C-G, Zhu M, Xing R, Cui J-T, Li W-M, et al. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer. Mol Cancer. 2016;15:1\u201314.","journal-title":"Mol Cancer"},{"issue":"8","key":"3418_CR58","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11095-024-03757-4","volume":"41","author":"Y Takakura","year":"2024","unstructured":"Takakura Y, Hanayama R, Akiyoshi K, Futaki S, Hida K, Ichiki T, et al. Quality and safety considerations for therapeutic products based on extracellular vesicles. Pharm Res. 2024;41(8):1573\u201394.","journal-title":"Pharm Res"},{"issue":"1","key":"3418_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02312-w","volume":"10","author":"G Xu","year":"2025","unstructured":"Xu G, Jin J, Fu Z, Wang G, Lei X, Xu J, et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther. 2025;10(1):255.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03418-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03418-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03418-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:02:22Z","timestamp":1791457342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03418-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3418"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03418-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all human participants prior to their inclusion in the study. All procedures involving animals were conducted in accordance with national regulations governing the care and use of laboratory animals. The experimental protocols conformed to the ethical standards outlined in the Declaration of Helsinki and received approval from the Ethics Committee of Islamic Azad University (IR.IAU.CTB.REC.1403.180; IR.IAU.CTB.REC.1403.216).","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"318"}}